Your browser doesn't support javascript.
loading
High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation.
Pedraza, Alexandra; Jorge, Sofia; Suárez-Lledó, María; Pereira, Arturo; Gutiérrez-García, Gonzalo; Fernández-Avilés, Francesc; Rosiñol, Laura; Llobet, Noemí; Solano, Teresa; Urbano-Ispízua, Álvaro; Rovira, Montserrat; Martínez, Carmen.
Afiliação
  • Pedraza A; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain.
  • Jorge S; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain.
  • Suárez-Lledó M; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain.
  • Pereira A; Hemotherapy and Hemostasis Department, Hospital Clínic, Barcelona, Spain.
  • Gutiérrez-García G; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Hospital Clínic, Barcelona, Spain; Institute Josep Carreras, Hospital Clínic, Barcelona, Spain.
  • Fernández-Avilés F; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Hospital Clínic, Barcelona, Spain; Institute Josep Carreras, Hospital Clínic, Barcelona, Spain.
  • Rosiñol L; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Hospital Clínic, Barcelona, Spain; Institute Josep Carreras, Hospital Clínic, Barcelona, Spain.
  • Llobet N; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain.
  • Solano T; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain.
  • Urbano-Ispízua Á; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Hospital Clínic, Barcelona, Spain; Institute Josep Carreras, Hospital Clínic, Barcelona, Spain.
  • Rovira M; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Hospital Clínic, Barcelona, Spain; Institute Josep Carreras, Hospital Clínic, Barcelona, Spain.
  • Martínez C; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Hospital Clínic, Barcelona, Spain; Institute Josep Carreras, Hospital Clínic, Barcelona, Spain. Elec
Transplant Cell Ther ; 27(7): 619.e1-619.e8, 2021 07.
Article em En | MEDLINE | ID: mdl-33895157
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tacrolimo / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tacrolimo / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha